Wolverine Trading
ATXS

Wolverine Trading’s Astria Therapeutics ATXS Stock Holding History

Wolverine Trading’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$80K Buy
+10,872
New +$73.6K ﹤0.01% 5284
2022
Q1 		– Sell
-12,836
Closed -$76.4K – 5373
2021
Q4 		$65K Buy
+12,836
New +$84.4K ﹤0.01% 5243

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Wolverine Trading's ATXS Position: Q3 2025 in Review

Wolverine Trading opened a new position in Astria Therapeutics (ATXS) in Q3 2025: 10,872 shares worth $80K. The stake represents ﹤0.01% of the portfolio and ranks #5284 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in ATXS as recently as Q4 2021.

Wolverine Trading first reported a position in ATXS in Q4 2021 and has held it in 2 quarters since. 115 funds tracked by Wall St. Rank hold ATXS as of Q3 2025.

  • Wolverine Trading held 10,872 shares of Astria Therapeutics worth $80K as of Q3 2025.
  • Astria Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Astria Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5284 holding.
  • Wolverine Trading first reported a position in Astria Therapeutics in Q4 2021 and has held it in 2 quarters since.
  • 115 funds tracked by Wall St. Rank held Astria Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.